AMAG Pharma (AMAG) Posts Smaller Q4 Loss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts AMAG Hot Sheet
Price: $13.75 --0%
Financial Fact:
Diluted (in shares): 42.11M
Today's EPS Names:
COHR, ATS, SICP, More
Financial Fact:
Diluted (in shares): 42.11M
Today's EPS Names:
COHR, ATS, SICP, More
Join SI Premium – FREE
AMAG Pharma (NASDAQ: AMAG) reported Q4 EPS of ($0.64), $0.45 better than the analyst estimate of ($1.09). Revenue for the quarter came in at $88.1 million versus the consensus estimate of $98.92 million.
GUIDANCE:
AMAG Pharma sees FY2019 revenue of $365-415 million, versus the consensus of $382.51 million.
For earnings history and earnings-related data on AMAG Pharma (AMAG) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Eversource Energy (ES) Tops Q3 EPS by 18c; offers guidance
- Melco Resorts & Entertainment (MLCO) Misses Q3 EPS by 9c
- PTC (PTC) Tops Q4 EPS by 7c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
